NINDS Funding Strategy

The Department of Health and Human Services (HHS), including NIH, operates under the "Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act" (Public Law 114-223) signed by President Obama on September 29, 2016.  This Act (CR) continues government operations through December 9, 2016 at 99.504 percent of the FY 2016 enacted level.

Continuing the procedures identified under NOT-OD-16-046 and consistent with NIH practices during the CRs of FY 2006 – 2016, the NIH will issue non-competing research grant awards at a level below that indicated on the most recent Notice of Award (generally up to 90% of the previously committed level). Upward adjustments to awarded levels will be considered after FY 2017 appropriations are enacted, but NIH expects institutions to monitor their expenditures carefully during this period.  All legislative mandates that were in effect in FY 2016 (see NOT-OD-16-044 and NOT-OD-16-048) remain in effect under this CR, as well as the salary limitation set at Executive Level II of the Federal Pay Scale (see NOT-OD-16-059) and the Ruth L. Kirschstein National Research Service Award stipend levels and tuition/fees (see NOT-OD-16-062).

All approved applications from 2016 September/October Council will be funded in accordance with the NINDS FY2016 funding strategy which applies competing administrative reductions of 12.5% to modular and 17.5% to non-modular grants.

As in recent fiscal years (see NOT-OD-13-064), inflationary increases for future year commitments are no longer provided for all competing and non-competing research grant awards issued by the NINDS. However, support requested and approved in the competing application for fluctuations in research needs will be considered.